MOTS - C 10mg - x1 10mg Vial

1 x 10 mg Vials

MOTS-C 10 mg

MOTS-C is a mitochondrial-derived peptide studied for its role in metabolism, energy regulation, and healthy aging. Research highlights its potential to support glucose metabolism, promote exercise-like benefits, and enhance overall cellular health, making it a focus in regenerative and metabolic studies.

1 x 10 mg MOTS-C Powder

Third-Party Tested

Delta Pharmaceuticals MOTS-C Lyophilized Powder 10 mg is designed for advanced peptide exploration, offering high-purity MOTS-C in a convenient, ready-to-reconstitute format. A vial contains 10 mg of lyophilized MOTS-C powder. The MOTS-C powder consistently exceeds 98.5% purity, ensuring a reliable and consistent product. Independent third-party testing for identity, purity, and endotoxins guarantees transparency and quality. Detailed reconstitution instructions are included for ease of use, making it ideal for those who demand simplified peptide applications.

What is MOTS-C?

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino- acid peptide encoded by mitochondrial DNA. It plays an important role in metabolic regulation, insulin sensitivity, and energy balance. Research suggests MOTS-C may mimic some of the beneficial effects of exercise, supporting performance, healthy aging, and resilience against metabolic stress.

Research-Based Applications:

  • Metabolic Regulation: Studied for enhancing glucose metabolism and fat utilization.
  • Weight Management: Explored for potential in weight management and obesity prevention through improved insulin sensitivity.
  • Exercise Performance: Researched for mimicking exercise-like pathways to support endurance and energy use.
  • Longevity Support: Investigated for protective and anti-aging effects in relation to age-associated decline.

Standard Dosage Protocol

Research suggests typical dosages range from 5 mg to 10 mg, administered 2–3 times per week for an initial loading phase of 4–6 weeks, followed by a maintenance phase of 5 mg once every 1–2 weeks.

For instance, a common protocol may include:

  • Weeks 1–4: 5–10 mg administered 2–3 times per week.
  • Weeks 5 onward: 5 mg once every 1–2 weeks for maintenance.

Reconstitution Instructions

MOTS-C Amount: 10 mg
Bacteriostatic Water: 2 mL
Concentration: 5.0 mg/mL (5000 mcg/mL)
Desired Dose: 5 mg
Draw up: 1.0 mL (100 units on U-100 insulin syringe)

Usage Notes:

  • MOTS-C is typically dosed at 5–10 mg, 2–3 times per week during loading phase.
  • Maintenance dosing may be reduced to 5 mg once every 1–2 weeks.
  • Always use sterile technique when reconstituting peptides.
  • Store reconstituted peptides in refrigerator (2–8°C).

Legal Disclaimer:

These products are not intended to diagnose, treat, cure, or prevent any disease. These products are intended for research and developmental purposes only. The content provided on this website is for informational purposes only and should not be considered medical advice.
Do not use these products for human consumption unless recommended by a licensed healthcare professional who has evaluated the specific circumstances and potential risks associated with their use.
© 2025 Delta Pharma GMBH. All rights reserved.